The global gelatin market is anticipated to achieve a valuation of USD 5.1 billion by 2028, exhibiting a noteworthy Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period up to 2023. This growth trajectory is notably driven by the pharmaceutical sector, poised to experience rapid expansion. The market’s ascent is propelled by the escalating demand for “free-from” food items, coupled with a heightened focus on health among consumers. Furthermore, the surge in the popularity of gelatin, rich in protein content, has engendered robust demand from the nutraceutical and sports nutrition domains.
Within the spectrum of sources, the animal-origin segment is projected to dominate in 2023. Gelatin, commonly derived from the partial hydrolysis of collagen extracted from diverse animal sources such as marine life, mammals, poultry, and even insects, underscores this trend. Commercial production predominantly hinges on bovine and porcine bones and hides, with a smaller-scale application of marine-sourced gelatin.
Of particular significance, Europe stands out as the region experiencing the swiftest growth in the gelatin market. This phenomenon can be attributed to the region’s populace of health-conscious individuals who harbor a strong affinity for nutritious, clean-label foods. Additionally, the burgeoning pharmaceutical industry further fuels this trend. Europe accommodates several key players in the gelatin industry including Gelita AG, PB Leiner, Trobas Gelatine B.V., and Lapi Gelatine S.P.A. This concentration of manufacturers has engendered a flurry of product launches, collaborations, and acquisitions, all tailored to meet the escalating demands of the food, beverage, and pharmaceutical sectors.
Prominent entities in the gelatin market landscape encompass Darling Ingredients, Tessenderlo Group, Nitta Gelatin, Inc., Gelita AG, Weishardt, Lapi Gelatine Spa, India Gelatine & Chemicals Ltd., Trobas Gelatine B.V., Sterling, Roxlor, Suheung, and Ewald Gelatin GmbH.
